MAGNETIC RESONANCE IMAGING CHARACTERISTICS OF THE NEUROMYELITIS OPTICA SPECTRUM DISORDER

Nguyễn Văn Sỹ1, Nguyễn Văn Tuận2,
1 Hanoi Medical University
2 Bach Mai Hospital

Main Article Content

Abstract

Objective: To describe the magnetic resonance imaging (MRI) characteristics of patients with neuromyelitis optica spectrum disorder (NMOSD). Subjects and Methods: We study 42 patients who were confirmed NMOSD diagnosis based on the 2015 consensus criteria. All patients underwent magnetic resonance imaging of the brain and spinal cord. Results: The amounts of patients who had abnormalities of the spinal cord, brain, both brain, and spinal cord, and optic nerve were 85.7%, 42.9%, 33.3%, and 23.8% respectively. On the brain MRI, the percentage of injury on the periependymal dorsal brainstem /cerebellum dorsal medulla was highest and accounted for 26.2%, followed by the dorsal medulla with 19%; the hypothalamus, the third ventricle periependymal (16,7%); the surrounding of the lateral ventricles (14,3%) and the white matter lesions adjacent to the occipital horn of the lateral ventricles (4.8%). 100% of spinal cord lesions were seen in the central, 52,8% in the cervical spinal cord and mostly was three or above vertebral segment in length (83.3%). In the group of patients with AQP4 positive, the abnormality was 86.1%. 50% of cases had cord edema while 73.8% of cases had contrast enhancement injury. Conclusion: In NMOSD, MRI lesions are not only in the spinal cord and optic nerve but also in the brain: brainstem, diencephalic and cerebral hemispheres.

Article Details

References

1. Wingerchuk D M, Banwell B, Bennett J L, et al. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 85(2), 177-189. doi:10.1212/WNL.0000000000001729
2. Lennon V A, Wingerchuk D M, Kryzer T J, et al. (2004). A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet, 364(9451), 2106-2112. doi:10.1016/S0140-6736(04)17551-X
3. Thompson A J, Banwell B L, Barkhof F, et al. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol, 17(2), 162-173. doi:10.1016/S1474-4422(17)30470-2
4. Drori T, & Chapman J. (2014). Diagnosis and classification of neuromyelitis optica (Devic's syndrome). Autoimmun Rev, 13(4-5), 531-533. doi:10.1016/j.autrev.2014.01.034
5.O'Riordan J I, Gallagher H L, Thompson A J, et al. (1996). Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry, 60(4), 382-387. doi:10.1136/jnnp.60.4.382
6. Kim W, Kim S H, Huh S Y, et al. (2012). Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int, 2012, 735486. doi:10.1155/2012/735486
7. Kim H J, Paul F, Lana-Peixoto M A, et al. (2015). MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology, 84(11), 1165-1173. doi:10.1212/WNL.0000000000001367
8. Pittock S J, Weinshenker B G, Lucchinetti C F, et al. (2006). Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol, 63(7), 964-968. doi:10.1001/archneur.63.7.964
9. Mehdipour-Dastjerdi R, Ashtari F, Shaygannejad V, et al. (2018). The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder. Iran J Neurol, 17(2), 58-63.
10. Wang K Y, Chetta J, Bains P, et al. (2018). Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review. Br J Radiol, 91(1086), 20170690. doi:10.1259/bjr.20170690